The following article is being retracted from publication in the Journal of Journal of Maternal-Fetal & Neonatal Medicine:
“Supraventricular tachycardia in neonates: antiarrhythmic drug choice dilemma” by M.C. Tavera, P.P. Bassareo, P. Neroni, C. Follese, D. Manca, S. Montis, R. Tumbarello, Volume 24(3), pp.541-544, DOI: 10.3109/14767058.2010.509915
http://www.tandfonline.com/doi/full/10.3109/14767058.2010.509915
We were made aware by a third party that sections of this article are substantially similar to sections of the following article previously published in Drug Safety Concept:
Jean-Pierre Pfammatter and Urs Bauersfeld, 1998, “Safety Issues in the Treatment of Paediatric Supraventricular Tachycardias”, Drug Safety Concept, 18(5): 345–356.
http://link.springer.com/article/10.2165%2F00002018-199818050-00004
The similarity was due to the authors submitting a ‘non-final version’ of their article for review. We note that we received, peer-reviewed, accepted, and published the article in good faith based on warranties made by the authors with respect to originality and of our policy on publishing ethics and integrity.
We have therefore taken the decision to retract the paper.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘retracted'.